Ketryx, the agentic continuous compliance platform for safety-critical product development, announced today that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. Hawkins also participated in the company’s Series B financing, signaling strong industry support for Ketryx’s mission to streamline compliance in life sciences.
Ketryx helps companies in safety-critical industries—including medical devices, pharmaceuticals, and robotics—accelerate product development by automatically generating compliant documentation, maintaining continuous traceability, and enabling safe and verifiable AI at scale within existing tools. The platform overlays current workflows to reduce manual work by up to 90 percent, closing compliance gaps and improving both speed and quality across the product lifecycle.
Hawkins brings decades of leadership experience from Medtronic, where he served as Chairman and CEO from 2007 to 2011, and from his tenure on the boards of several public and private companies. His expertise in navigating complex regulatory environments will be instrumental as Ketryx expands its footprint in the life sciences sector.
“Bill’s deep understanding of the medical device industry and his track record of driving innovation make him an invaluable addition to our board,” said Ketryx CEO. “His insights will help us continue to solve the AI bottleneck in life sciences, enabling our customers to bring safer products to market faster.”
The company’s platform is trusted by four of the world’s top five medical device manufacturers. By automating documentation and traceability, Ketryx addresses the critical challenge of integrating AI into regulated development processes without disrupting existing workflows. This approach is particularly relevant as regulatory bodies increasingly emphasize the need for verifiable AI in safety-critical applications.
Hawkins expressed enthusiasm for Ketryx’s mission: “Ketryx is tackling one of the most pressing issues in life sciences—how to harness AI while maintaining rigorous compliance. I look forward to working with the team to scale this solution across the industry.”
Ketryx’s Series B financing round, which includes Hawkins’ participation, will support further product development and market expansion. The company aims to extend its platform to additional safety-critical sectors, such as automotive and aerospace, where compliance demands are similarly stringent.
For more information, visit www.ketryx.com.
